Form D · Biotechnology

Avicenna Biosciences, Inc.

Durham, NC · CIK 0001824034

Offering snapshot reported Oct 30, 2025 · SEC filing

Reported sold
$70.7K
Offering amount: $70.7K
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 17, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$35.3K$70.7KOct 27, 2022: $18,000.00Oct 27, 2022Mar 22, 2023: $27,450.00Oct 30, 2025: $70,650.00Oct 30, 2025

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$27,450 → $70,650

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 30, 2025Amendment$70,650$43,200vs Mar 22, 20231SEC filing
Jul 16, 2024Initial$6,000,000No comparison1SEC filing
Feb 23, 2024Initial$6,000,000No comparison1SEC filing
Mar 22, 2023Amendment$27,450$9,450vs Oct 27, 20221SEC filing
Dec 30, 2022Initial$3,000,000No comparison1SEC filing
Oct 27, 2022Initial$18,000No comparison1SEC filing
Sep 14, 2020Initial$2,500,000No comparison1SEC filing

Offering details

Securities
Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-463082

Source: Form D, filed Oct 30, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Pieter Burger Director, Executive
John Hamer Director
Thomas Kaiser Director, Executive
Dennis Langer Director
Christopher Meldrum Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
101 W. Chapel Hill Street, Suite 210
Durham, NC, 27701